Study aim: The relation between melatonin and inflammation control in patients with COVID-19 Design: Forty patients enter the intervention and control groups randomly and in parallel by the (...) : Patients enter the study with mild to moderate COVID-19 who receive Hydroxy chloroquine and have CTscan and

Study aim: To study the effect of nimesulide in the treatment of COVID-19 pneumonia. Design: Uncontrolled Longitudinal study, single-center, comprising 60 patients with COVID-19 infection Settings and (...) COVID-19 infection or treated. Exclusion Criteria: • Participant is allergic to any of the study groups

Study aim: The effect of diet on the clinical symptoms of COVID-19 outpatients with the attitude of (...) with clinical symptoms of covid 19 and RT-PCR testing or chest CT positive for the disease that (...) criteria: 1- Pregnant and lactating women 2- COVID-19 patients in hospital or admitted to hospital

Study aim: Evaluation of isotretinoin effects on Covid-19 disease Design: This study is A phase 3; non-randomized single-blind clinical trial, 50 patients more than 18 years with positive Covid-19 test (...) . Participants/Inclusion and exclusion criteria: Definite Covid-19 disease; older than 18 years; duration of

Study aim: Determination of the effects of COVID-19 convalescent plasma in acute respiratory distress syndrome due to COVID-19 Design: Present study is randomized, parallel, clinical trial. Settings and conduct: the present study will be done in hospitalized COVID-19 patients at Urmia University of

Study aim: Evaluation the efficacy and safety of Favipiravir Administration in comparison with Lopinavir-ritonavir in COVID-19 patients Design: Prospective clinical trial with parallel randomized groups (...) who diagnosed with COVID-19 by RT-PCR test and are over 18 years old. These patients are included if

Study aim: The outcome assessment of the early tracheotomy and orotracheal intubation in COVID-19 patients. Design: Two arm parallel group without blinding and randomization Settings and conduct: The study conducted on the total confirmed COVID-19 patients using the Polymerase Chain Reaction (PCR

Study aim: To determine the effectiveness of hemoperfusion to remove cytokines-induced by COVID-19 (...) blindness, ten patients with severe forms of COVID-19, Phase 2. Settings and conduct: This study will be (...) COVID-19 and before intubation.CT scan of lungs, biochemical tests, hospitalization period, need to

Study aim: evaluating the effectiveness of tenofovir + hydroxychloroquine regiment compared to hydroxychloroquine alone in patients with COVID-19 penumonia Design: A randomized single-blinded superiority (...) exclusion criteria: A total of 86 patients with COVID-19 induced pneumonia who have been diagnosed according

manifestations of COVID-19 patients Design: This study is double blinded clinical trial in phase 2 which will be carried out on 125 COVID-19 patients into two groups (hospitalized & non-hospitalized patients (...) carried out on 125 COVID-19 patients into two groups (hospitalized & non-hospitalized patients) in Velayat

and laboratory outcomes of patients with Coronavirus Disease 2019 (COVID-19) hospitalized in RAZI (...) postoperative care and outcome assessment. Two group of 50 patients with confirmed COVID-19 will be entered to (...) outcomes will be assessed. Participants/Inclusion and exclusion criteria: Patients with Confirmed COVID-19

Study aim: Convalescent plasma of COVID-19 patients is effective for respiratory failure of these patients Design: In 30 patients with confirmed COVID-19 with respiratory failure or ARDS, in addition to (...) entering the study: 1. Age over 18 years old 2. Proven laboratory COVID-19 disease and positive PCR

exercises on cranio-vertebral angle and respiratory function in the elderly with a history of Covid-19 (...) with a history of the Covid-19 virus six months ago and have head forward and chest kyphosis are (...) months have passed since the definitive diagnosis of COVID-19 and negative PCR test; more than six months

patients with new coronavirus (Covid-19). Design: Clinical trial with control group, with parallel groups (...) Covid-19 infection whose disease has been confirmed by real-time PCR molecular test or on the basis of (...) addition to the standard treatment of Covid-19, plasmapheresis was also performed for the patients

severe COVID-19 Design: A randomized, single-blinded clinical trial with a parallel-group design of 60 (...) hospitalized COVID-19 patients confirmed by PCR test and chest CT-scans will participate. Patients will be (...) will receive laser acupuncture treatment in addition to the current standard care for COVID-19. Laser

morbidity of Covid-19 patients. Design: A simple randomized, double-blind, placebo-controlled clinical (...) with Covid -19 admitted to the ICU of Sina Hospital in Tabriz will be included.Patients are randomly (...) respiratory distress syndrome caused by covid-19 in these patients. In this study, evaluator, and researcher

Study aim: The efficacy of bromhexine hydrochloride in the prevention of COVID-19 disease will be (...) intervention and control groups, Phase 2, 3500 close contacts of patients with COVID-19 disease Settings and (...) with COVID-19 will be selected and randomly divided into two groups. The control group will receive a

-6 inhibition and cytokine release prevention can subside hypoxic respiratory failure of COVID-19 patients 3-IL- 6 inhibition can reduce mortality of respiratory failure in COVID-19 patients 4- IL-6 inhibition may reduce end organ failure in COVID-19 patients Design: 10 Covid-19 patients with clinical and

process of patients with COVID 19 in patients with this disease Design: Determining the effect of skin test purified protein derivative (PPD) on the recovery process of patients with COVID 19 in patients (...) : Criteria for entering the study: All patients diagnosed with covid-19. Output criteria: Patients with

Study aim: Identifying effects of Shilajit (Mumiai) on clinical course and outcomes of COVID-19 (...) population: All patients with a moderate form of COVID-19 disease who are refered to Allameh Bohlool Gonabadi (...) treatment. Participants/Inclusion and exclusion criteria: Inclusion criteria: Diagnosed moderate COVID-19

Kaletra (lopinavir and ritonavir) tablets in patients with acute respiratory COVID-19 infection Design (...) -center trial. 20 patients with COVID-19 infection admitted to Bohlool hospital and have not responded to (...) COVID-19 plus intravenous immunoglobulin (IVIG),They will receive 400 mg/kg/day of IVIg in 3 doses (max

Study aim: 1-Determining the clinical effect of Ramdzivir in reducing the load of Covid 19 virus in (...) Ramdzivir in reducing the load of Covid 19 virus in patients 3. Comparison of the clinical effect of Ramdzivir and Ramdzivir with Molnopiravir in reducing the load of Covid virus 19 in patients 4- Determining

Study aim: The effectiveness of phr-160 spray in improving the respiratory status of Covid-19 (...) Covid-19 with CT scan and obtaining informed consent from the patient and checking the inclusion (...) RT-PCR, Confirmation of Covid-19 using CT scan, Signing a informed consent form ٍExclusion creteria

to COVID-19 Design: Clinical trial with control group, single-blind, randomized, phase 2 on 15 (...) pneumonia Covid 19 infection should be confirmed by RT-PCR or lung CT scan. Both genders Age ≥18 years at (...) by the COVOID-19 , who are on antiviral medication according to national protocol. Patients will be

Study aim: Determining the effectiveness of pentoxifylline in diabetic patients with covid-19 (...) . Settings and conduct: At least 24 inpatient diabetic patients with COVID-19 over the age of 18 and (...) : Having type 1 or 2 diabetes Infected with covid-19 Hospitalization in the non-specialized departments of